rs182950534

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004484.4(GPC3):​c.1167-8T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00436 in 1,201,309 control chromosomes in the GnomAD database, including 11 homozygotes. There are 1,621 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 2 hom., 96 hem., cov: 24)
Exomes 𝑓: 0.0045 ( 9 hom. 1525 hem. )

Consequence

GPC3
NM_004484.4 splice_region, intron

Scores

2
Splicing: ADA: 0.001398
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.690

Publications

0 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant X-133692502-A-G is Benign according to our data. Variant chrX-133692502-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 239934.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00293 (330/112726) while in subpopulation NFE AF = 0.00441 (235/53347). AF 95% confidence interval is 0.00394. There are 2 homozygotes in GnomAd4. There are 96 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004484.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
NM_004484.4
MANE Select
c.1167-8T>C
splice_region intron
N/ANP_004475.1I6QTG3
GPC3
NM_001164617.2
c.1236-8T>C
splice_region intron
N/ANP_001158089.1P51654-3
GPC3
NM_001164618.2
c.1119-8T>C
splice_region intron
N/ANP_001158090.1B4DTD8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
ENST00000370818.8
TSL:1 MANE Select
c.1167-8T>C
splice_region intron
N/AENSP00000359854.3P51654-1
GPC3
ENST00000394299.7
TSL:1
c.1236-8T>C
splice_region intron
N/AENSP00000377836.2P51654-3
GPC3
ENST00000631057.2
TSL:1
c.1005-8T>C
splice_region intron
N/AENSP00000486325.1P51654-2

Frequencies

GnomAD3 genomes
AF:
0.00294
AC:
331
AN:
112673
Hom.:
2
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000871
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00129
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.00442
Gnomad OTH
AF:
0.00854
GnomAD2 exomes
AF:
0.00251
AC:
458
AN:
182449
AF XY:
0.00243
show subpopulations
Gnomad AFR exome
AF:
0.000686
Gnomad AMR exome
AF:
0.00256
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00100
Gnomad NFE exome
AF:
0.00430
Gnomad OTH exome
AF:
0.00289
GnomAD4 exome
AF:
0.00451
AC:
4907
AN:
1088583
Hom.:
9
Cov.:
27
AF XY:
0.00430
AC XY:
1525
AN XY:
354389
show subpopulations
African (AFR)
AF:
0.000839
AC:
22
AN:
26229
American (AMR)
AF:
0.00293
AC:
103
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.000104
AC:
2
AN:
19308
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30114
South Asian (SAS)
AF:
0.0000742
AC:
4
AN:
53898
European-Finnish (FIN)
AF:
0.00111
AC:
45
AN:
40475
Middle Eastern (MID)
AF:
0.00219
AC:
9
AN:
4104
European-Non Finnish (NFE)
AF:
0.00545
AC:
4541
AN:
833513
Other (OTH)
AF:
0.00395
AC:
181
AN:
45770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
153
306
458
611
764
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00293
AC:
330
AN:
112726
Hom.:
2
Cov.:
24
AF XY:
0.00275
AC XY:
96
AN XY:
34862
show subpopulations
African (AFR)
AF:
0.000869
AC:
27
AN:
31080
American (AMR)
AF:
0.00431
AC:
46
AN:
10666
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2722
European-Finnish (FIN)
AF:
0.00129
AC:
8
AN:
6214
Middle Eastern (MID)
AF:
0.00457
AC:
1
AN:
219
European-Non Finnish (NFE)
AF:
0.00441
AC:
235
AN:
53347
Other (OTH)
AF:
0.00843
AC:
13
AN:
1542
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00346
Hom.:
25
Bravo
AF:
0.00327

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
4
not specified (4)
-
-
1
GPC3-related disorder (1)
-
-
1
Hereditary ataxia (1)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Intellectual disability (1)
-
-
1
Simpson-Golabi-Behmel syndrome type 1 (1)
-
-
1
Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
10
DANN
Benign
0.83
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0014
dbscSNV1_RF
Benign
0.042
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs182950534; hg19: chrX-132826530; API